S Sörenson

1.0k total citations
36 papers, 791 citations indexed

About

S Sörenson is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, S Sörenson has authored 36 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in S Sörenson's work include Lung Cancer Research Studies (18 papers), Neuroendocrine Tumor Research Advances (10 papers) and Cancer therapeutics and mechanisms (5 papers). S Sörenson is often cited by papers focused on Lung Cancer Research Studies (18 papers), Neuroendocrine Tumor Research Advances (10 papers) and Cancer therapeutics and mechanisms (5 papers). S Sörenson collaborates with scholars based in Sweden, Denmark and Norway. S Sörenson's co-authors include Bengt Bergman, Marianne Sullivan, Jan Holmgren, Leif Lindholm, Stein Sundstrøm, Christian von Plessen, Ulf Aasebø, P Dombernowsky, Jan Vilsvik and RJ Stephens and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

S Sörenson

35 papers receiving 739 citations

Peers

S Sörenson
Marina Djurfeldt Canada
Giovanni Pietro Ianniello Italy
Paul Rebattu France
Ulla Brix Tange Denmark
Nicolò Borsellino Italy
Barbara Melotti Italy
B. Farrús Spain
Mariagrazia Distefano Italy
Dimitri Korol Switzerland
Yunfei Wang United States
Marina Djurfeldt Canada
S Sörenson
Citations per year, relative to S Sörenson S Sörenson (= 1×) peers Marina Djurfeldt

Countries citing papers authored by S Sörenson

Since Specialization
Citations

This map shows the geographic impact of S Sörenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Sörenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Sörenson more than expected).

Fields of papers citing papers by S Sörenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Sörenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Sörenson. The network helps show where S Sörenson may publish in the future.

Co-authorship network of co-authors of S Sörenson

This figure shows the co-authorship network connecting the top 25 collaborators of S Sörenson. A scholar is included among the top collaborators of S Sörenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Sörenson. S Sörenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maagaard, Mathias, et al.. (2025). Remimazolam for procedural sedation. European Journal of Anaesthesiology. 42(4). 298–312. 1 indexed citations
2.
3.
Sörenson, S, et al.. (2024). Primary outcomes and anticipated effect sizes in randomised clinical trials assessing peripheral and truncal nerve blocks: a systematic scoping review. British Journal of Anaesthesia. 134(2). 535–544. 1 indexed citations
4.
Cullen, M.H., Petr Zatloukal, S Sörenson, et al.. (2008). A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer. Annals of Oncology. 19(5). 939–945. 64 indexed citations
5.
Plessen, Christian von, Trond‐Eirik Strand, Tore Wentzel‐Larsen, et al.. (2008). Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study. Thorax. 63(10). 866–871. 8 indexed citations
6.
Plessen, Christian von, Bengt Bergman, R. M. Bremnes, et al.. (2006). Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. British Journal of Cancer. 95(8). 966–973. 124 indexed citations
7.
8.
9.
10.
11.
Østerlind, Kell, M Hansen, Fred R. Hirsch, et al.. (1991). Combination chemotheraphy of limited-stage small-cell lung cancer. A controlled trial on 221 patients comparing two alternating regimens. Annals of Oncology. 2(1). 41–46. 11 indexed citations
12.
Bergman, Bengt, Marianne Sullivan, & S Sörenson. (1991). Quality of Life During Chemotherapy for Small Cell Lung Cancer :I. An evaluation with generic health measures. Acta Oncologica. 30(8). 947–957. 62 indexed citations
13.
Bergman, Bengt & S Sörenson. (1990). Hospitalization During Chemotherapy for Small Cell Lung Cancer. Acta Oncologica. 29(8). 977–982. 3 indexed citations
14.
Bergman, Bengt & S Sörenson. (1988). Smoking and effect of chemotherapy in small cell lung cancer. European Respiratory Journal. 1(10). 932–937. 22 indexed citations
15.
Bergman, Bengt & S Sörenson. (1987). Return to work among patients with small cell lung cancer.. PubMed. 70(1). 49–53. 15 indexed citations
16.
Sörenson, S, et al.. (1983). Interstitial pneumonia due to sulfasalazine.. PubMed. 64(3). 229–33. 10 indexed citations
17.
Sörenson, S, Kell Østerlind, P Dombernowsky, & Hansen Hh. (1983). Phase II study of vinblastine in small cell carcinoma of the lung.. PubMed. 67(3). 293–5. 5 indexed citations
18.
Sörenson, S, et al.. (1982). Phase II study of procarbazine in small cell carcinoma of the lung.. PubMed. 66(2). 273–5. 11 indexed citations
19.
Sörenson, S. (1981). Treatment of small cell carcinoma of the lung.. PubMed. 62(5). 315–31. 4 indexed citations
20.
Dombernowsky, P, S Sörenson, Joseph Aisner, & Hansen Hh. (1979). cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.. PubMed. 63(4). 543–5. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Djurfeldt Breakdown of academic impact, for papers by Giovanni Pietro Ianniello Breakdown of academic impact, for papers by Paul Rebattu Breakdown of academic impact, for papers by Ulla Brix Tange Breakdown of academic impact, for papers by Nicolò Borsellino Breakdown of academic impact, for papers by Barbara Melotti Breakdown of academic impact, for papers by B. Farrús Breakdown of academic impact, for papers by Mariagrazia Distefano Breakdown of academic impact, for papers by Dimitri Korol Breakdown of academic impact, for papers by Yunfei Wang
Rankless by CCL
2026